ThermoGenesis Holdings had the pleasure of having our very own C.E.O., Dr. Chris Xu, featured in a Q&A article by BioPharm International where a panel of experts were asked questions about the growth, challenges & opportunities within the cell & gene therapy industry. We invite you to read the BioPharm international article which can be … Continued
Preparing cell samples is an essential part of achieving success in cell and gene therapy manufacturing. Achieving high-quality results requires that samples be pure, with high viability and free of any damage caused by harsh retrieval techniques. Current cell isolation techniques can be time-consuming and cause stress to cell samples, which is why there is … Continued
Contract Development Manufacturing Organization (CDMO) partnerships are on the rise due to an increased demand for cell therapies and the limited availability of Good Manufacturing Practice (GMP) approved manufacturing facilities and other resources. Pharmaceutical & biotechnology companies are needing to outsource their product development and manufacturing in order to try to meet these demands, even … Continued
Cell separation is an essential part of the manufacturing process for CGT cell therapies like CAR-T. To get the best results, cell samples must be purified and prepared properly. Purifying cells is achieved by a different approaches (positive selection, negative selection, etc.) which all can use different methodologies to accomplish their goals. Some of the … Continued
Cell and gene therapy is growing and new therapies are rapidly evolving , leading to an increase in the demand for efficient and effective cell therapy manufacturing. Each step in the process must be meticulously carried out in order to achieve the best possible results, increasing the likelihood of effectiveness for certain therapies. This begins … Continued
Personalized treatments are the wave of the future in medicine. With regenerative medicine treatments like CAR-T cell therapy receiving FDA approval, the demand for the manufacturing of cell therapies is only going to continue to grow. However, there are unique logistical challenges in the cell therapy manufacturing process that are preventing these treatments from becoming … Continued
Cell-based therapies are growing in popularity and are in higher demand, creating a need for scalability in manufacturing. There are several challenges associated with the mass production of cell therapies, the most concerning of which being the safety and efficacy of the manufacturing process to ensure patients are receiving the highest-quality treatment. Utilizing automated, … Continued
The use of Contract Development and Manufacturing Organizations (CDMO) services has risen in recent years due to challenges associated with cell manufacturing. Pharmaceutical companies derive many benefits from working with an experienced CDMO partner who can help navigate the process of scaling and commercializing a product, and this practice is becoming increasingly popular. In addition, … Continued
A key element of all cell and gene therapies (CGTs) is cryopreservation, the controlled freezing of cell samples. In cell therapy manufacturing, cell samples are collected and stored for future use, often for decades, so the proper collection, cryopreservation and retrieval of these samples is essential for safe and effective CGTs. In addition, it’s also … Continued
Cell and gene therapies (CGT) are gaining greater popularity in the community as viable regenerative medicine options. Although there has been a lot of progress made in a relatively short amount of time, there are challenges to overcome before these treatments can become more mainstream. As a solution to the concerns with rapid, scalable manufacturing, … Continued